α-CsPbI3 nanocrystals (NCs) with poor stability prevent their wide applications in optoelectronic fields. Ca2+ (1.00 Å) as a new B-site doping ion can successfully boost CsPbI3 NC performance with both improved phase stability and optoelectronic properties. With a Ca2+/Pb2+ ratio of 0.40%, both phase and photoluminescence (PL) stability could be greatly enhanced. Facilitated by increased tolerance factor, the cubic phase of its solid film could be maintained after 58 days in ambient condition or 4 h accelerated aging process at 120°C. The PL stability of its solution could be preserved to 83% after 147 days in ambient condition. Even using UV light to accelerate aging, the T50 of PL could boost 1.8-folds as compared to CsPbI3 NCs. Because Ca2+ doping can dramatically decrease defect densities of films and reduce hole injection barriers, the red light-emitting diodes (LEDs) exhibited about triple enhancement for maximum the external quantum efficiency (EQE) up to 7.8% and 2.2 times enhancement for half-lifetime of LED up to 85 min. We believe it is promising to further explore high-quality CsPbI3 NC LEDs via a Ca2+-doping strategy.
State-of-the-art
external quantum efficiencies (EQEs) have exceeded
20% for near-infrared, red, and green perovskite light-emitting diodes
(PeLEDs) so far. Nevertheless, the cutting-edge blue counterparts
demonstrate an inferior device performance, which impedes the commercialization
and industrialization of PeLEDs in ultrahigh-definition displays.
As the most popular hole transport layer, poly(3,4-ethylenedioxythiophene):polystyrenesulfonate
(PEDOT:PSS) bears the acidic and hygroscopic drawbacks, which deteriorates
the device efficiency and long-term stability of blue PeLEDs. In this
work, the basic amino acids with zwitterionic characteristics are
proposed to modulate the pH of PEDOT:PSS, which are arginine, lysine,
and histidine. It is found that they play a triple function to the
blue perovskite films: modulating the acidity of PEDOT:PSS, controlling
the crystalline process, and passivating the defects at the PEDOT:PSS/perovskite
interface. As a result, the utilization of neutral PEDOT:PSS leads
to a significant enhancement in stability and photoluminescence quantum
yield. Eventually, the pure-blue PeLEDs achieve a record EQE of 5.6%
with the emission peak at 467 nm. This research proves that the interfacial
engineering of hole transport layers is a reliable strategy to enhance
the device efficiency and operation stability of blue PeLEDs.
Graphene
is a promising flexible transparent electrode, and significant
progress in graphene-based optoelectronic devices has been accomplished
by reducing the sheet resistance and tuning the work function. Herein,
phosphomolybdic acid (PMA) is proposed as a novel p-type chemical
dopant for graphene, and the optical and electrical properties of
graphene are investigated systematically. As a result, the monolayer
graphene electrode with lower sheet resistance and work function are
obtained while maintaining a high transmittance. The Raman spectrum
proves the p-type doping effect of PMA on graphene, and the X-ray
photoelectron spectroscopy results reveal the mechanism, which is
that the electrons transfer from graphene to PMA through the Mo–O–C
bond. Furthermore, using the PMA-doped graphene anode, organic and
perovskite light-emitting diodes obtained the maximum efficiencies
of 129.3 and 15.6 cd/A with an increase of 50.8 and 36.8% compared
with the pristine counterparts, respectively. This work confirms that
PMA is a potential p-type chemical dopant to achieve an ideal graphene
electrode and demonstrates the feasibility of PMA-doped graphene in
the practical application of next-generation displays and solid-state
lighting.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.